OncoVista (OVIT.BB) Reinstated on the OTC Bulletin Board
03 Diciembre 2009 - 1:51PM
Business Wire
OncoVista Innovative Therapies, Inc. (OTCBB: OVIT) announced
today that its application for reinstatement on the
Over-The-Counter Bulletin Board has been accepted.
“OncoVista is very pleased to be reinstated on the OTC Bulletin
Board,” said Dr. Alexander L. Weis, President of OncoVista
Innovative Therapies, Inc., “because it is another indication of
the Company’s progress to build shareholder value.”
OncoVista Innovative Therapies, Inc. is a biopharmaceutical
company involved in the development of targeted anticancer
therapies by using tumor-associated biomarkers. In conjunction with
its subsidiary, AdnaGen AG which is based in Langenhagen, Germany,
the Company has developed and currently markets patented diagnostic
kits in Europe for the detection of circulating tumor cells in
patients with breast, colon, ovarian and prostate cancers under the
brand name AdnaGen™. The Company has also developed research
products for the detection of steroid receptors and cancer stem
cells and has research contracts in place with major pharmaceutical
companies and recognized U.S. research facilities.
OncoVista has an experienced management team specialized in
development of targeted, anticancer drugs led by Dr. Alexander L.
Weis. OncoVista’s targeted drug development uses the proprietary,
state-of-the-art molecular platform of AdnaGen AG. Further
information on OncoVista can be found at www.oncovista.com.
The OTC Bulletin Board® (OTCBB) is a regulated quotation service
that displays real-time quotes, last-sale prices, and volume
information in over-the-counter (OTC) equity securities. OTCBB
securities include national, regional, and foreign equity issues,
warrants, units, American Depositary Receipts (ADRs), and Direct
Participation Programs. The provides access to more than 3,300
securities; includes more than 230 participating Market Makers;
electronically transmits real-time quote, price, and volume
information in domestic securities, foreign securities and ADRs;
and displays indications of interest and prior-day trading activity
in Direct Participation Programs. For more information, go to
www.otcbb.com,
Forward-Looking Statements: A number of statements contained in
this press release are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties that could cause actual
results to differ materially from those expressed or implied in the
applicable statements. These risks and uncertainties could cause
actual results to differ materially from those expressed or implied
in the applicable statements.
OncoVista Innovative The... (CE) (USOTC:OVIT)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
OncoVista Innovative The... (CE) (USOTC:OVIT)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
